← Back to Search

Radiation Therapy

Radiation for Myxoid Liposarcoma (DOREMY Trial)

Phase 2
Waitlist Available
Led By Rick Haas, MD,PhD
Research Sponsored by The Netherlands Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the percentage of pathological responses will be pathologically assessed on the resection specimen; this procedure will take on average 7-10 working days. after surgery, patients will be followed up to 10 years.
Awards & highlights

DOREMY Trial Summary

This trial is studying whether it is possible to reduce the amount of radiation given to patients before surgery for myxoid liposarcomas and still get the same tumor response.

Eligible Conditions
  • Myxoid Liposarcoma

DOREMY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the percentage of pathological responses will be pathologically assessed on the resection specimen; this procedure will take on average 7-10 working days. after surgery, patients will be followed up to 10 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the percentage of pathological responses will be pathologically assessed on the resection specimen; this procedure will take on average 7-10 working days. after surgery, patients will be followed up to 10 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Pathological description of the percentage pathological responses after reduced RT (radiotherapy) dose from (conventionally) 25 x 2 Gy to 18 x 2 Gy (in the current study)

DOREMY Trial Design

1Treatment groups
Experimental Treatment
Group I: RadiationExperimental Treatment1 Intervention
Dose reduction of preoperative radiotherapy in MLS from 50 Gy to 36 GY.

Find a Location

Who is running the clinical trial?

The Netherlands Cancer InstituteLead Sponsor
291 Previous Clinical Trials
211,394 Total Patients Enrolled
1 Trials studying Myxoid Liposarcoma
300 Patients Enrolled for Myxoid Liposarcoma
Rick Haas, MD,PhDPrincipal InvestigatorThe Netherlands Cancer Institute
1 Previous Clinical Trials
12 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
2010. "Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02106312.
All > Osa > Liposarcoma
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top